A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer

Koneru, Mythili ; O’Cearbhaill, Roisin ; Pendharkar, Swati ; Spriggs, David R ; Brentjens, Renier J

Journal of translational medicine, 2015-03, Vol.13 (1), Article 102 [Periódico revisado por pares]

London: BioMed Central

Texto completo disponível